GenomeDx Biosciences today announced that data presented at the 2015 American Society of Clinical Oncology Annual Meeting demonstrate that the Decipher® Prostate Cancer Classifier is a significant ...
ANN ARBOR, Mich., March 06, 2018 (GLOBE NEWSWIRE) -- Television, print and online media are filled with ads warning consumers of the dangers of the “dark web,” images of ominous lines of code and ...
SAN DIEGO, June 7, 2017 /PRNewswire/ -- GenomeDx Biosciences today announced results from three recent publications demonstrating the clinical validity of the Decipher® Prostate Cancer Classifier ...